Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans

Journal of the American Society of Nephrology

Volumn 12, Issue 8, 2001, Pages 1706-1712

  Perinotto, P ^a   Biggi, A ^a   Carra, N ^a   Orrico, A ^a   Valmadre, G ^a   Dall'Aglio, P ^a   Novarini, A ^a   Montanari, A ^a  

^a Istituto di Clinica Medica Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; INDOMETACIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION;

EID: 0034911831     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Nitric oxide and the glomerulus
2. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins
3. Mechanisms underlying pressure-related natriuresis: The role of the renin-angiotensin and prostaglandins system. State of the art lecture
4. Effects of acetaminophen and ibuprofen on renal function in the stressed kidney
5. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II
6. Pressor and renal vasoconstrictor responses to acute systemic nitric oxide synthesis are independent of sympathetic nervous system and angiotensin II
7. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition
8. Angiotensin II blockade does not prevent renal effect of L-NAME in sodium repleted humans
9. Relationship between basal NO release and cyclooxygenase products in the normal rat kidney
10. Role of prostaglandins and nitric oxide in mediating renal response to volume expansion
11. Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension
12. Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition
13. Basal nitric oxide synthesis in essential hypertension
14. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
15. Aging and endothelial function in the normotensive subjects and patients with essential hypertension
16. Impairment of endothelial function in salt-sensitive hypertension in humans
17. Renal response to L-arginine in salt-sensitive patients with essential hypertension
18. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans
19. Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension
20. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension. Modulation of nitric oxide synthesis by salt intake
21. Chronic nitric oxide inhibition model six years on
22. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: Effects of antihypertensive therapy
23. Nitric oxide synthase activity and renal injury in genetic hypertension
24. Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension
25. The renal response to converting enzyme inhibition and the treatment of sodium-sensitive hypertension
26. The kidney in blood pressure regulation and development of hypertension
27. Drug concentration response relationship in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist
28. Effects of nonsteroidal anti-inflammatory drugs in healthy subjects
29. Role of prostaglandins in the natriuresis of head-out water immersion in humans
30. Measurement of renal function without urine collection: A critical evaluation of the constant-infusion technique for determination of inulin and para-aminohippurate
31. Abnormal renal responses to calcium entry blockade in normotensive offspring of hypertensive parents
32. Selective endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans
33. 1166 polymorphism in essential hypertensives on a high sodium diet
34. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dog
35. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans
36. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME
37. Salt-dependent renal effects of angiotensin II antagonist in healthy subject
38. Effects of verapamil on the renal action induced by nitric oxide and prostaglandin synthesis inhibition
39. Stimulation of endogenous endothelin release in the anesthetized rat
40. Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals
41. Na and vasoactive hormones in healthy humans
42. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans
43. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications
44. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis
45. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension
46. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
47. The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesic for patients at risk